King Luther Capital Management Corp Novartis Ag Transaction History

King Luther Capital Management Corp

  • $21.4 Billion
  • Q1 2025

A detailed history of King Luther Capital Management Corp transactions in Novartis Ag stock. As of the latest transaction made, King Luther Capital Management Corp holds 11,068 shares of NVS stock, worth $1.28 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,068
Previous 10,375 6.68%
Holding current value
$1.28 Million
Previous $1.01 Million 22.2%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$97.14 - $115.57 $67,318 - $80,090
693 Added 6.68%
11,068 $1.23 Million
Q4 2024

Feb 07, 2025
SELL
$96.78 - $117.18 $6,484 - $7,851
-67 Reduced 0.64%
10,375 $1.01 Million
Q3 2024

Nov 08, 2024
BUY
$106.13 - $120.89 $97,533 - $111,097
919 Added 9.65%
10,442 $1.2 Million
Q2 2024

Aug 12, 2024
BUY
$92.57 - $107.37 $42,211 - $48,960
456 Added 5.03%
9,523 $1.01 Million
Q1 2024

May 13, 2024
BUY
$95.27 - $108.47 $83,837 - $95,453
880 Added 10.75%
9,067 $877,000
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $14,670 - $16,144
-159 Reduced 1.91%
8,187 $826,000
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $73,510 - $81,580
-776 Reduced 8.51%
8,346 $850,000
Q2 2023

Aug 10, 2023
SELL
$92.52 - $104.91 $134,801 - $152,853
-1,457 Reduced 13.77%
9,122 $920,000
Q1 2023

May 11, 2023
BUY
$80.03 - $92.81 $46,657 - $54,108
583 Added 5.83%
10,579 $973,000
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $32,184 - $39,413
-426 Reduced 4.09%
9,996 $906,000
Q3 2022

Nov 10, 2022
SELL
$74.61 - $87.26 $98,783 - $115,532
-1,324 Reduced 11.27%
10,422 $792,000
Q2 2022

Aug 11, 2022
BUY
$80.52 - $93.75 $194,214 - $226,125
2,412 Added 25.84%
11,746 $993,000
Q1 2022

May 11, 2022
SELL
$80.11 - $90.62 $26,596 - $30,085
-332 Reduced 3.43%
9,334 $819,000
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $179,723 - $198,733
-2,255 Reduced 18.92%
9,666 $845,000
Q3 2021

Nov 10, 2021
SELL
$81.78 - $95.14 $407,918 - $474,558
-4,988 Reduced 29.5%
11,921 $975,000
Q2 2021

Aug 13, 2021
BUY
$85.24 - $94.15 $552,184 - $609,903
6,478 Added 62.1%
16,909 $1.54 Million
Q1 2021

May 12, 2021
SELL
$83.5 - $98.47 $364,811 - $430,215
-4,369 Reduced 29.52%
10,431 $892,000
Q4 2020

Feb 10, 2021
SELL
$78.07 - $94.43 $105,082 - $127,102
-1,346 Reduced 8.34%
14,800 $1.4 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $170,029 - $188,370
-2,070 Reduced 11.36%
16,146 $1.4 Million
Q2 2020

Aug 12, 2020
SELL
$80.93 - $91.1 $55,032 - $61,947
-680 Reduced 3.6%
18,216 $1.59 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $253,069 - $354,554
-3,581 Reduced 15.93%
18,896 $1.56 Million
Q4 2019

Feb 12, 2020
BUY
$84.35 - $95.37 $1.28 Million - $1.44 Million
15,139 Added 206.31%
22,477 $2.13 Million
Q2 2019

Aug 12, 2019
BUY
$75.4 - $92.8 $267,066 - $328,697
3,542 Added 93.31%
7,338 $670,000
Q4 2018

Feb 12, 2019
SELL
$73.66 - $82.02 $76,901 - $85,628
-1,044 Reduced 21.57%
3,796 $326,000
Q3 2018

Nov 13, 2018
SELL
$66.94 - $77.43 $22,424 - $25,939
-335 Reduced 6.47%
4,840 $417,000
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $42,126 - $47,610
649 Added 14.34%
5,175 $391,000
Q1 2018

May 08, 2018
BUY
$70.39 - $84.15 $10,910 - $13,043
155 Added 3.55%
4,526 $366,000
Q4 2017

Feb 12, 2018
BUY
$72.33 - $77.64 $4,122 - $4,425
57 Added 1.32%
4,371 $367,000
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $319,839 - $333,342
4,314
4,314 $370,000

Others Institutions Holding NVS

# of Institutions
1,524
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email